These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2968065)

  • 41. [Vaccines against the hepatitis B virus. The outstanding problems].
    Carreño V; Quiroga JA
    Rev Clin Esp; 1990 Oct; 187(5):247-8. PubMed ID: 2102538
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevention of hepatitis B virus infection].
    Sato S; Ishikawa K
    Rinsho Byori; 1987 Jul; 35(7):726-33. PubMed ID: 3669384
    [No Abstract]   [Full Text] [Related]  

  • 43. [Active hepatitis B immunization--current status of development and effectiveness].
    Baumgarten R; Fengler JD
    Z Arztl Fortbild (Jena); 1986; 80(10):393-4. PubMed ID: 2944291
    [No Abstract]   [Full Text] [Related]  

  • 44. Control of hepatitis B in Australia. The case for alternative strategies.
    Gust ID
    Med J Aust; 1992 Jun; 156(12):819-21. PubMed ID: 1534864
    [No Abstract]   [Full Text] [Related]  

  • 45. [The present and future of vaccination against hepatitis B].
    Horton J
    Cas Lek Cesk; 1986 Dec; 125(52):1593-4. PubMed ID: 2948650
    [No Abstract]   [Full Text] [Related]  

  • 46. Vaccine choice and program participation rates when two hepatitis B vaccines are offered.
    Harris AA; Daly-Gawenda D; Hudson EK
    J Occup Med; 1991 Jul; 33(7):804-7. PubMed ID: 1832443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis vaccine.
    Newsline People AIDS Coalit N Y; 1998; ():31-2. PubMed ID: 11367503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Social Welfare Board's Statute Book. Social Welfare Board's general advice on preventive measures against hepatitis B].
    Jordemodern; 1991 Oct; 104(10):347-55, 358-60. PubMed ID: 1837291
    [No Abstract]   [Full Text] [Related]  

  • 49. [The prevalence of the HBsAg carrier state among pregnant women and its effect on newborn infants. IV. Our experience in using hepatitis B vaccine and hepatitis B immunoglobulin to immunize infants born to mothers who carry HBsAg].
    Iliev B; Stambolov B; Marinova E; Khitkova Kh; Khristov M
    Akush Ginekol (Sofiia); 1989; 28(6):37-42. PubMed ID: 2633642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of antibodies to human immunodeficiency virus (HIV) in health workers after hepatitis B vaccination.
    Israel Z; Bose M; Rodrigues J; Aramkalle B; Athalye N; Pavri KM
    J Assoc Physicians India; 1988 Feb; 36(2):179. PubMed ID: 2972693
    [No Abstract]   [Full Text] [Related]  

  • 51. Is nonresponsiveness to hepatitis B vaccine due to latent hepatitis B virus infection?
    Luo KX; Wang LP; Nie J; Jiang S
    J Infect Dis; 1992 Apr; 165(4):777-8. PubMed ID: 1532408
    [No Abstract]   [Full Text] [Related]  

  • 52. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 53. Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine.
    Carne CA; Weller IV; Waite J; Briggs M; Pearce F; Adler MW; Tedder RS
    Br Med J (Clin Res Ed); 1987 Apr; 294(6576):866-8. PubMed ID: 3105779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effectiveness and tolerance of genetically engineered vaccines for hepatitis B--a comparative study].
    Schmid K; Strebl H; Heck KJ; Weltle D; Raithel HJ
    Gesundheitswesen; 1992 May; 54(5):219-22. PubMed ID: 1535816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B vaccination in newborn babies.
    Heijtink RA; Weber YA; Mazel JA
    Lancet; 1988 May; 1(8596):1226. PubMed ID: 2897038
    [No Abstract]   [Full Text] [Related]  

  • 56. [Persistent HBsAg antigenemia in newborn infants following intrauterine HBV infection. Cause for the failure of the prevention of perinatal HBV transmission].
    Pongpipat D; Suvatte V; Assateerawatts A
    Monatsschr Kinderheilkd; 1986 Jul; 134(7):473-4. PubMed ID: 2943988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Hepatitis B virus in schools; a risk?].
    Del Canho R; Grosheide PM; Schalm SW
    Ned Tijdschr Geneeskd; 1991 May; 135(19):862. PubMed ID: 1828539
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis B infection post Engerix B vaccination.
    Huengsberg MI; Radcliffe KW; Boxall EH
    Genitourin Med; 1993 Oct; 69(5):406-7. PubMed ID: 8244366
    [No Abstract]   [Full Text] [Related]  

  • 59. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 60. The control of hepatitis B virus infection with vaccine in Japanese nursery schools.
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H
    Am J Epidemiol; 1987 Sep; 126(3):474-9. PubMed ID: 2956878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.